DNMT3A mutations are rare in childhood acute myeloid leukemia

Haematologica

Volumn 96, Issue 8, 2011, Pages 1238-1239

  Thol, Felicitas ^a   Heuser, Michael ^a   Damm, Frederik ^a   Klusmann, Jan Henning ^a   Reinhardt, Katarina ^a   Reinhardt, And Dirk ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

AML; Childhood; DNMT3A; Mutation

Indexed keywords

ARGININE; CD135 ANTIGEN; DNA METHYLTRANSFERASE 3A; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; BLOOD ANALYSIS; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL EXAMINATION; CODON; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXON; FEMALE; FOLLOW UP; GENE FREQUENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTICENTER STUDY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME;

ADOLESCENT; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MUTATION; TREATMENT OUTCOME;

EID: 79961085843     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.046839     Document Type: Letter

References (12)

1. Armstrong SA, Mabon ME, Silverman LB, Li A, Gribben JG, Fox EA, et al. FLT3 mutations in childhood acute lymphoblastic leukemia. Blood. 2004;103(9):3544-6.
2. Hollink IH, Zwaan CM, Zimmermann M, Arentsen-Peters TC, Pieters R, Cloos J, et al. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia. 2009;23(2):262-70.
3. Liang DC, Shih LY, Huang CF, Hung IJ, Yang CP, Liu HC, et al. CEBPa mutations in childhood acute myeloid leukemia. Leukemia. 2005;19(3):410-4.
4. Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, Balgobind BV, Arentsen-Peters ST, Alders M, et al. Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood. 2009;113(23):5951-60.
5. Damm F, Thol F, Hollink I, Zimmermann M, Reinhardt K, van den Heuvel-Eibrink MM, et al. Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups. Leukemia. 2011 Jun 7. [Epub ahead of print]
6. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363(25):2424-33.
7. Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43(4): 309-15.
8. Thol F, Damm F, Lüdeking A, Winschel C, Wagner K, Morgan M, et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol. 2011 Jun 13. [Epub ahead of print]
9. Ho PA, Kutny MA, Alonzo TA, Gerbing RB, Joaquin J, aimondi SC, et al. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2011;Pediatr Blood Cancer. 2011;57(2):204-9.
10. Creutzig U, Zimmermann M, Ritter J, Reinhardt D, Hermann J, Henze G, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia. 2005;19(12):2030-42.
11. Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann, Niemeyer CM, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol. 2006;24(27):4499-506.
12. Creutzig U, Zimmermann M, Bourquin JP, Dworzak MN, Fleischhack G, von Neuhoff C, et al. CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML-BFM98 and 2004. Pediatr Blood Cancer. 2011 Apr 7. doi: 10.1002/pbc.22955, [Epub ahead of print]